Related Experiment Video
Updated: May 13, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Populene D analogues: design, concise synthesis and antiproliferative activity
Kachi R Kishore Kumar Reddy1, Giovanna B Longato, João E de Carvalho
1Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes, 748, CP 26077, CEP São Paulo 05513-970, SP, Brazil. analucia@cpqba.unicamp.br
Researchers synthesized nine populene D analogues using iodine-catalyzed Prins cyclization. The study investigated their antiproliferative activity against cancer cell lines, identifying selective compounds.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Populene D analogues are compounds with potential therapeutic applications.
- Developing efficient synthetic routes for novel analogues is crucial for drug discovery.
- Understanding the antiproliferative activity of these compounds is essential for cancer research.
Purpose of the Study:
- To synthesize novel populene D analogues.
- To evaluate the antiproliferative activity of the synthesized compounds against various cancer cell lines.
- To identify compounds with selective toxicity towards specific cancer types.
Main Methods:
- An iodine-catalyzed Prins cyclization was employed for the efficient synthesis of nine populene D analogues.
- The synthesized pyran derivatives were tested for their antiproliferative effects.
- In vitro assays were conducted using multiple human cancer cell lines, including NCI-ADR/RES, OVCAR-3, and HT29.
Main Results:
- Nine populene D analogues were successfully synthesized.
- An isochromene derivative exhibited moderate antiproliferative activity (mean logGI(50) = 0.91).
- Several compounds demonstrated selectivity towards NCI-ADR/RES, OVCAR-3, and HT29 tumor cell lines.
Conclusions:
- The study established an efficient synthetic pathway to populene D analogues.
- The identified isochromene analogue shows potential as an anticancer agent.
- Selective compounds offer promise for targeted cancer therapy development.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Inhibitors of Bacterial DNA Synthesis
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antifungal Agents
